Phase I trial of CymVectin to prevent cytomegalovirus infections in pregnancy in adolescents.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2012
At a glance
- Drugs VCL 6365 (Primary)
- Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
- Focus Adverse reactions
- Sponsors Vical
- 09 Feb 2012 This trial has not yet been initiated but it appears than Vical still intends to conduct it.
- 22 Feb 2010 Status changed from not stated to not yet recruiting.
- 22 Feb 2010 New trial record